DOTmed May 6, 2024
Gus Iversen

GE HealthCare stock has dropped over 10% since last week, when the company unveiled its first quarter earnings.

Here are seven key takeaways from the company’s financial disclosure:

Stable revenue amid challenges: GE HealthCare reported revenue down 1% year-over-year, totaling $4.6 billion for the first quarter of 2024. Organic revenue growth remained flat, indicating a balance between declining volumes and positive pricing adjustments.

Weakness in China: The medical device maker’s revenue from China market, which constitutes nearly 13% of its total revenue, dropped more than 11% in the quarter. “Many of GE HealthCare’s suppliers were noting weakness in China last quarter, so it makes some sense that we would see that come through (to this quarter),” BTIG analyst Ryan Zimmerman...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health IT, Medical Devices, Technology
Pulse Biosciences names new CEO, reassigns former leader
R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee
How new tariffs on Chinese medical products will affect US healthcare
PCOS infertility treatment developer May Health raises $25M
Medical device instructions need a rewrite, APIC says

Share This Article